OakChart

Haemonetics Corp

HAEHealthcare·Medical Devices·USA·Mid·NYSE·Nov 11 • 11:17 AM ET

120.93-1.43 (-1.17%)
2026-11-11 17:17 CET
Market cap
5,571.97 USD m
Revenue, TTM
1,382.46 USD m
Net income, TTM
103.91 USD m
Free cash flow, TTM
298.24 USD m
EPS diluted, TTM
2.24
P/E
54.10
Compare

Price

HAE against its 20, 50 and 200-day averages
2050200beatmiss
60.0080.00100.00120.001.4M2.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HAEclose 120.9320-day 119.9350-day 112.52200-day 80.70120.9352w high52w low

8.4% under the 52-week high of 132.00 on 5 Nov 2026. 52-week low 51.00 on 8 May 2026. Last 15 sessions, 14.3% high to low

Profile

HAE
52-week range, 86% of the way up
51.00132

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

IndexRUT
Employees3009
IPOMay 10, 1991
Beta0.58
ATR, 14d4.42
Rel volume0.31
Short float8.06%
Insider own1.88%
Inst own107.64%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap5.51B
Enterprise Value6.37B
Income103.91M
Sales1.38B
Book/sh19.74
Cash/sh5.73
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees3009
IPOMay 10, 1991

Ratios

P/E54.10
Forward P/E19.55
PEG1.49
P/S3.98
P/B6.13
P/C21.12
P/FCF18.46
EV/EBITDA17.43
EV/Sales4.61
Quick Ratio1.83
Current Ratio2.84
Debt/Eq1.25
LT Debt/Eq1.24
Option/ShortYes / Yes

Earnings

EPS (ttm)2.24
EPS next Y6.19
EPS next Q1.28
EPS this Y7.39%
EPS next Y16.14%
EPS next 5Y13.11%
EPS past 3/5Y-2.90% 5.81%
Sales past 3/5Y4.51% 8.91%
EPS Y/Y TTM-34.22%
Sales Y/Y TTM4.11%
EPS Q/Q22.79%
Sales Q/Q9.30%
EarningsNov 05 BMO
EPS/Sales Surpr.4.56% 3.65%

Ownership

Insider Own1.88%
Insider Trans0.00%
Inst Own107.64%
Inst Trans3.35%
ROA4.28%
ROE11.89%
ROIC5.16%
Gross Margin56.63%
Oper. Margin18.51%
Profit Margin7.52%
SMA200.83%
SMA507.47%
SMA20049.86%
Trades-

Technical

Shs Outstand45.52M
Shs Float44.68M
Short Float8.06%
Short Ratio4.99
Short Interest3.60M
52W High132.00 -8.39%
52W Low51.00 137.12%
Volatility6.25% 3.38%
ATR (14)4.42
RSI (14)55.83
Beta0.58
Rel Volume0.31
Avg Volume721.51K
Volume70,027

Performance

Perf Week-5.09%
Perf Month-0.65%
Perf Quarter33.80%
Perf Half Y112.12%
Perf YTD50.88%
Perf Year68.59%
Perf 3Y40.42%
Perf 5Y104.83%
Perf 10Y210.40%
Recom1.67
Target Price139.40
Prev Close122.36
Price120.93
Change %-1.17%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 17, 2026UpgradeCCitigroupNeutral → Buy$123+1.7%
May 22, 2026UpgradeBBofA SecuritiesNeutral → Buy$80-33.8%
May 12, 2026ReiteratedBBarrington ResearchOutperform$94 → $89-26.4%
Dec 15, 2025DowngradeNNeedhamBuy → Hold
Dec 11, 2025DowngradeCCitigroupBuy → Neutral$88-27.2%
Aug 11, 2025DowngradeRRaymond JamesStrong Buy → Outperform$78-35.5%
Aug 08, 2025ReiteratedBBarrington ResearchOutperform$95 → $86-28.9%
Aug 08, 2025DowngradeJJP MorganOverweight → Neutral$62-48.7%
Jul 09, 2025UpgradeCCitigroupNeutral → Buy$90-25.6%
Jun 26, 2025InitiatedRRobert W. BairdOutperform$87-28.1%

Peers

Mkt cap
TickerCompanyMkt cap
TFXTeleflex Incorporated6.12B
MMSIMerit Medical Systems Inc5.26B
CERSCerus Corp431.17M
ABTAbbott Laboratories190.06B
PENPenumbra Inc12.68B
BDXBecton Dickinson & Co57.68B
ICUIICU Medical Inc4.48B
BAXBaxter International Inc13.56B
BSXBoston Scientific Corp66.04B
GRFSGrifols SA ADR2.25B

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B

News

latest 14 of 206
  • Haemonetics Beats And Raises Again On CSL-Fueled Plasma Surge, But A Margin Guide Cut Shows The Cost Of Growth (Earnings Whispers)
  • Haemonetics: Fiscal Q2 Earnings Snapshot (Associated Press)
  • Haemonetics Corporation Announces Second Quarter Fiscal 2027 Financial Results Available on Investor Relations Website (PR Newswire)
  • Haemonetics Must Prove Its Vascular Turnaround Is Durable After A 40% Rally (Earnings Whispers)
  • Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line (PR Newswire)
  • Loading…
  • Haemonetics Announces FDA Approval of PerQseal Elite Vascular Closure System (PR Newswire)
  • HAE, PCRX Stocks Hit Multi-Year Highs Amid Broader Market Selloff Whats Driving The Momentum Today? (Stocktwits) +17.46%
  • Haemonetics shares jump as CSL sets 2027 rollout of plasma devices (Proactive)
  • Haemonetics Soars 12% on CSL Update: Plasma Giant to Roll Out NexSys Across U.S. Centers (TIKR)
  • Haemonetics Stock Surges as Plasma Deal Opens Door to More Revenue (Barrons.com)
  • Haemonetics stock surges 17% on CSL Plasma supply deal update (Investing.com)
  • Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026 (PR Newswire)
  • HAE, TWST Stocks Jump To Over 5-Year Highs Whats Driving The Gains Today? (Stocktwits)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-11-051.3501.2911.000357.76345.1511
2026Q12026-08-061.1401.0770.722339.38327.8611
2025Q42026-05-071.2901.273-0.436346.35336.8311
2025Q32026-02-051.3101.2500.952339331.9211
2025Q22025-11-061.2701.1100.812327.32311.5111
2025Q12025-08-071.1001.0080.704321.39301.7910
2024Q42025-05-081.2401.2201.172330.6329.3610
2024Q32025-02-061.1901.1740.740348.54352.7210
2024Q22024-11-071.1201.0730.660345.51342.5710
2024Q12024-08-081.0201.0060.744336.17335.087
2023Q42024-05-090.9000.8920.396343.29329.537
2023Q32024-02-081.0400.9420.607336.25320.847
2023Q22023-11-020.9900.8880.485318.18313.157
2023Q12023-08-081.0500.7230.799311.33292.746
2022Q42023-05-110.7700.7040.574304.42290.798
2022Q32023-02-070.8500.8170.643305.3299.568

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY2.3902.3341.039967.58968.5
2019FY3.3103.3431.477988.48995.92
2020FY2.3502.5631.549870.46868.82
2021FY2.5802.5320.845993.2986.15
2022FY3.0302.9672.2441,1691,155
2023FY3.9603.9592.2871,3091,295
2024FY4.5704.5443.3051,3611,360
2025FY4.9604.9442.0501,3341,325
2026FY-5.326--1,439
2027FY-6.186--1,580
2028FY-7.179--1,723
2029FY-8.550--1,866

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-061122357.92351.72366.6
2026Q3S2026-11-051122358.02352.14366.6
2026Q3S2026-10-201110357.78351.2366.64
2026Q3S2026-10-151121357.78351.17366.64
2026Q3S2026-10-131121357.78351.17366.64
2026Q3S2026-10-121121357.81351.17366.64
2026Q3S2026-10-091121357.6351.17366.64
2026Q3S2026-10-071121357.78351.17366.64
2026Q3S2026-09-171121357.56351.2366.64
2026Q3S2026-08-171111356.65351.2361.83
2026Q3S2026-08-071111356.69351.2362
2026Q3S2026-08-061111356.7351.2362
2026Q3S2026-07-251100356.51349361.34
2026Q3S2026-07-211101356.51349361.34

Estimate history

EPS, annual0.8521.0391.4771.5490.8452.2442.2873.3052.0552.2352
Period201720182019202020212022202320242025TTM
EPS, quarterly0.660.741.1720.7040.8120.952-0.4360.7220.997
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual903.923967.579988.479870.463993.1961168.661309.0551360.8241334.0271382.46
Period201720182019202020212022202320242025TTM
Sales, quarterly345.511348.542330.599321.394327.315338.967346.351339.38357.759
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual52.34351.0250.32350.86951.12450.44950.78848.21645.25345.524
Period201720182019202020212022202320242025MRQ
Shares, quarterly50.38150.23548.21648.15946.74746.82945.25345.47145.524
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,382.461,334.031,360.821,309.061,168.66993.20870.46988.48967.58
Cost of Goods Sold Incl. D&A599.61590.97645.50632.52578.43515.04474.85479.46510.87
Gross Profit782.84743.06715.33676.54590.23478.16395.62509.02456.71
Selling, General and Administrative Excl. Other526.89498.44492.99468.40423.03366.91301.09313.99320.37
Research and Development61.9358.8061.1352.2349.0845.9831.6930.0035.71
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income255.96244.62222.34208.14167.20111.2594.52195.03136.34
Interest Expense37.0026.239.8916.5015.8818.5012.4316.7411.27
Unusual Expense76.9490.362.1343.759.1938.7241.9991.1351.44
Net Income Before Taxes142.01128.03212.07151.87141.4063.6372.9187.1573.63
Income Taxes38.1030.7244.3934.3126.0020.25-6.5610.6318.61
Consolidated Net Income103.9197.31167.68117.56115.4043.3879.4776.5355.02
Net Income From Continuing Operations103.9197.31167.68117.56115.4043.3879.4776.5355.02
Net Income103.9197.31167.68117.56115.4043.3879.4776.5355.02
EPS (Recurring)3.403.393.332.882.371.372.122.711.72
EPS (Basic, Before Extraordinaries)2.272.063.332.322.270.851.571.511.07
EPS (Diluted)2.242.053.312.292.240.841.551.481.04
EBITDA365.53356.34337.93305.35260.51209.00178.81305.32245.76
Non-Operating Income (Expense)-0.010.011.743.97-0.749.6032.810.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense28.8126.7223.4122.3820.2117.7825.5214.9313.58
Price To Earnings Ratio54.7454.7425.0134.6236.8574.9671.6067.49101.21
Price To Sales Ratio3.541.922.363.353.643.306.605.294.79
Gross Margin56.6355.7052.5751.6850.5148.1445.4551.5047.20
Operating Margin18.5118.3416.3415.9014.3111.2010.8619.7314.09
Net Margin7.527.2912.328.989.874.379.137.745.69
Shares Outstanding45.5245.2548.2250.7950.4551.1250.8750.3251.02
Market Capitalization5,571.975,571.973,192.594,334.594,174.533,231.285,641.725,012.704,462.09

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue357.76339.38346.35338.97327.31321.39330.60348.54
Cost of Goods Sold Incl. D&A147.47146.00158.59147.56143.89140.93148.68164.20
Gross Profit210.29193.38187.76191.41183.42180.47181.92184.34
Selling, General and Administrative Excl. Other135.40133.63136.02121.85116.14125.33130.46121.80
Research and Development17.0316.2114.4114.2914.5215.5815.9615.83
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income74.8959.7651.7569.5667.2855.1451.4662.54
Interest Expense11.8810.176.838.127.214.07-11.09
Unusual Expense0.152.0073.321.468.785.90-16.181.54
Net Income Before Taxes62.8647.57-28.4059.9851.2845.1770.7449.92
Income Taxes16.5514.56-8.2515.2312.6011.1412.7612.42
Consolidated Net Income46.3033.01-20.1544.7438.6834.0357.9837.49
Net Income From Continuing Operations46.3033.01-20.1544.7438.6834.0357.9837.49
Net Income46.3033.01-20.1544.7438.6834.0357.9837.49
EPS (Recurring)1.000.750.670.970.940.790.940.76
EPS (Basic, Before Extraordinaries)1.020.73-0.440.960.810.711.180.75
EPS (Diluted)1.000.72-0.440.950.810.701.170.74
EBITDA102.6586.8779.0796.9495.5383.9079.6791.57
Non-Operating Income (Expense)0.00-0.010.000.000.000.003.100.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense8.087.367.216.166.007.362.987.39
Price To Earnings Ratio54.7436.9115.4923.3814.8822.4925.0132.43
Price To Sales Ratio3.542.611.872.861.732.652.302.86
Gross Margin58.7856.9854.2156.4756.0456.1555.0352.89
Operating Margin20.9317.6114.9420.5220.5517.1615.5717.94
Net Margin12.949.73-5.8213.2011.8210.5917.5410.76
Shares Outstanding45.5245.4745.2546.8346.7548.1648.2250.24
Market Capitalization5,571.973,408.452,619.133,751.802,348.163,584.043,192.593,921.48

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments245.44306.76178.80284.47259.50192.31137.31169.35180.17
Short Term Receivables216.85202.66206.56179.14159.38127.56165.21185.03151.23
Inventories306.37365.14317.20259.38293.03322.61270.28194.34160.80
Other Current Assets66.2160.4166.3446.7344.1351.0730.8427.4128.98
Total Current Assets834.88934.98768.90769.72756.03693.55603.64576.12521.18
Net Property, Plant & Equipment345.38331.54366.63364.30311.23277.42305.63343.98332.16
Total Investments and Advances0.951.020.000.000.000.000.000.000.00
Intangible Assets1,104.021,060.01971.20742.00777.55831.93343.76338.51367.98
Deferred Tax Assets9.527.807.745.244.476.013.934.363.96
Other Assets101.17115.5981.1253.5610.4611.0310.1511.8012.06
Total Assets2,395.932,450.952,195.591,934.831,859.731,819.921,267.111,274.771,237.34
Short Term Debt Incl. Current Port. of LT Debt14.26311.6718.3618.95221.3424.7284.2927.67194.26
Accounts Payable51.0667.0073.3663.9358.3750.2950.7363.3655.27
Income Tax Payable----10.2319.2313.298.455.34
Other Current Liabilities217.28199.45208.66168.94152.32159.25126.51136.28129.84
Total Current Liabilities282.60578.11300.38251.82442.27253.50274.82235.76384.70
Long Term Debt1,260.46971.68855.52754.10615.14753.55357.53322.4559.42
Provision for Risks Charges0.000.000.000.000.0023.0721.8922.9724.73
Deferred Tax Liabilities38.0562.5862.6436.2028.7343.8310.5619.916.53
Other Liabilities18.5017.7417.0874.7224.1714.3115.205.819.53
Total Liabilities1,599.611,630.111,235.631,116.831,110.311,088.25680.00606.90484.91
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity796.32820.84959.96818.00749.42731.67587.11667.87752.43
Total Shareholders Equity796.32820.84959.96818.00749.42731.67587.11667.87752.43
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity796.32820.84959.96818.00749.42731.67587.11667.87752.43
Total Liabilities & Stockholders Equity2,395.932,450.952,195.591,934.831,859.731,819.921,267.111,274.771,237.34
Book Value Per Share17.6017.0218.9016.2114.6614.3811.6713.0914.37
Tangible Book Value Per Share-6.80-4.96-0.221.51-0.55-1.974.846.467.34
Full-Time Employees3,0093,0233,6573,0342,8212,7083,0043,2163,136
Price to Book Ratio6.203.524.595.104.317.728.546.944.75
Return on Assets4.027.225.696.082.365.156.024.383.68
Return on Equity12.0318.8313.2214.725.8612.0512.207.756.11
Return on Invested Capital4.739.356.487.343.185.358.105.565.61
Quick Ratio1.870.991.502.031.051.461.211.620.94
Current Ratio2.951.622.563.061.712.742.202.441.35

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income103.9197.31167.68117.56115.4043.3879.4776.5355.02
Depreciation109.58111.72115.5997.2293.3197.7584.29110.29109.42
Other Funds (Non Cash)126.91134.325.6452.7232.9541.3024.6062.9244.24
Funds from Operations321.11316.87283.69256.45246.44187.44168.49242.78222.03
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital23.82-23.65-101.96-74.7025.50-15.18-59.68-84.56-62.75
Cash from Operating Activities344.93293.22181.72181.75271.94172.26108.81158.22159.28
Capital Expenditures-46.69-32.78-39.28-66.30-110.19-96.51-37.04-48.76-118.96
Net Assets From Acquisitions-60.18-60.18-150.91-243.85-2.85-2.50-434.80-35.000.00
Sale of Fixed Assets and Businesses1.771.3866.543.312.4612.6646.4026.582.81
Purchase or Sale of Investments-19.11-36.07-17.14-15.55-33.200.000.000.000.00
Purchase of Investments-19.11-36.07-17.14-15.55-33.200.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-38.40-51.89-21.110.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-162.60-179.55-161.90-322.39-143.79-86.34-425.44-57.18-116.15
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-90.61-167.11483.337.21-67.986.55-3.23-162.98-146.56
Repurchase of Common Pref Stock-100.00-175.00-225.000.00-75.000.000.00-175.00-160.00
Sale of Common Pref Stock9.397.89708.337.217.026.55-3.2312.0213.45
Proceedsfrom Stock Options4.427.89708.335.604.384.21-9.443.370.00
Issuance or Reduction of Debt, Net-106.25-6.25-364.0237.75-9.62-17.50370.7331.8895.93
Change in Long Term Debt-106.25-6.25-364.0237.75-9.62-17.50430.73-13.1280.93
Issuance of Long Term Debt300.00300.00226.87110.000.000.00500.000.00347.78
Reduction of Long Term Debt-406.25-306.25-590.89-72.25-9.62-17.50-69.28-13.12-266.85
Net Financing Active Other Cash Flow-21.75-5.10-10.49-6.81-21.64-4.80-0.05-0.100.00
Other Financing Activities Uses-21.75-5.10-10.49-6.81-21.64-4.80-0.05-0.100.00
Cash from Financing Activities-218.60-178.46108.8238.16-99.25-15.75367.45-131.21-50.63
Exchange Rate Effect0.563.46-0.69-3.19-3.94-2.984.18-1.87-3.32
Net Change in Cash-35.71-61.32127.96-105.6724.9767.1954.99-32.04-10.82
Free Cash Flow298.24260.44142.45115.45161.7575.7571.77109.4640.32
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow16.409.8322.5038.0026.3143.2880.0847.79114.87
Deferred Taxes & Investment Tax Credit--26.47-5.22-11.044.785.01-19.87-6.9613.35

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments260.71223.38245.44363.37296.43292.90
Short Term Receivables224.95216.07216.85195.71207.07200.75
Inventories305.01306.74306.37321.19336.21360.53
Other Current Assets64.8664.6466.2163.4159.9858.98
Total Current Assets855.53810.83834.88943.67899.68913.16
Net Property, Plant & Equipment307.92303.78345.38297.23292.48286.87
Total Investments and Advances3.831.490.950.000.000.00
Intangible Assets1,083.471,091.401,104.021,026.561,034.461,057.93
Deferred Tax Assets9.359.439.527.337.577.84
Other Assets150.51148.47101.17216.09207.97196.29
Total Assets2,410.612,365.402,395.932,490.892,442.162,462.09
Short Term Debt Incl. Current Port. of LT Debt9.644.9614.26304.75304.33303.95
Accounts Payable71.6456.3451.0648.6961.6946.01
Other Current Liabilities219.56201.94217.28186.43182.29181.45
Total Current Liabilities300.84263.24282.60539.87548.32531.41
Long Term Debt1,114.121,169.201,260.46919.99920.39920.83
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities41.8238.6938.0555.9858.2059.49
Other Liabilities55.3357.1718.5063.6066.0768.07
Total Liabilities1,512.111,528.301,599.611,579.441,592.981,579.79
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity898.50837.10796.32911.45849.17882.30
Total Shareholders Equity898.50837.10796.32911.45849.17882.30
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity898.50837.10796.32911.45849.17882.30
Total Liabilities & Stockholders Equity2,410.612,365.402,395.932,490.892,442.162,462.09
Book Value Per Share19.7418.4117.6019.4618.1718.32
Tangible Book Value Per Share-4.06-5.59-6.80-2.46-3.96-3.65
Full-Time Employees--3,009---
Price to Book Ratio6.204.262.904.412.664.38
Return on Assets4.283.994.026.996.776.53
Return on Equity11.8911.2012.0319.3019.4718.27
Return on Invested Capital2.301.65-0.982.442.191.89
Quick Ratio1.831.911.871.151.031.04
Current Ratio2.843.082.951.751.641.72

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income46.3033.01-20.1544.7438.6834.03
Depreciation27.7627.1127.3227.3928.2528.76
Other Funds (Non Cash)13.3911.5490.2911.6919.0213.32
Funds from Operations90.0272.3377.0181.7585.2372.88
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital38.08-20.00-6.0711.8126.09-55.48
Cash from Operating Activities128.1052.3270.9493.56111.3217.39
Capital Expenditures-14.77-7.91-17.66-6.35-5.02-3.75
Net Assets From Acquisitions0.000.00-60.180.000.000.00
Sale of Fixed Assets and Businesses0.580.240.530.430.120.30
Purchase or Sale of Investments0.00-9.000.00-10.11-7.88-18.08
Purchase of Investments0.00-9.000.00-10.11-7.88-18.08
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-10.09-5.57-9.30-13.44-17.69-11.46
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-24.29-22.23-86.61-29.47-30.47-33.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock1.953.55-99.883.77-74.943.94
Repurchase of Common Pref Stock0.000.00-100.000.00-75.000.00
Sale of Common Pref Stock1.953.550.123.770.063.94
Proceedsfrom Stock Options0.000.007.89-3.480.003.48
Issuance or Reduction of Debt, Net-51.56-51.56-1.56-1.56-1.56-1.56
Change in Long Term Debt-51.56-51.56-1.56-1.56-1.56-1.56
Issuance of Long Term Debt0.000.00300.000.000.000.00
Reduction of Long Term Debt-51.56-51.56-301.56-1.56-1.56-1.56
Net Financing Active Other Cash Flow-18.00-3.51-0.06-0.17-0.05-4.82
Other Financing Activities Uses-18.00-3.51-0.06-0.17-0.05-4.82
Cash from Financing Activities-67.61-51.53-101.502.03-76.55-2.44
Exchange Rate Effect1.13-0.62-0.760.81-0.774.18
Net Change in Cash37.33-22.06-117.9366.943.53-13.87
Free Cash Flow113.3344.4253.2887.22106.3113.64
Price to Free Cash Flow16.4012.139.5912.248.9718.86

Revenue breakdown

Blood Center Products and Services2024: 261.12M 2025: 221.27M
Hospital Products and Services2024: 564.27M 2025: 588.30M
Plasma Products and Services2024: 535.43M 2025: 524.46M
Asia2024: 92.31M 2025: 87.21M
Europe2024: 175.66M 2025: 185.02M
Japan2024: 62.41M 2025: 68.20M
Other Country or Region2024: 19.54M 2025: 11.42M
United States2024: 1.01B 2025: 982.18M
Blood Center2024: 261.12M 2025: 221.27M
Hospital2024: 564.27M 2025: 588.30M
Plasma2024: 535.43M 2025: 524.46M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.06%3.6M44.7M726.66K
2026-10-157.68%3.4M44.6M735.21K
2026-09-306.81%3.0M44.6M695.35K
2026-09-157.67%3.4M44.6M754.81K
2026-08-316.41%2.9M44.6M841.04K
2026-08-146.19%2.8M44.6M858.16K
2026-07-316.55%2.9M44.6M887.87K
2026-07-156.06%2.7M44.6M899.33K
2026-06-306.53%2.9M44.6M877.84K
2026-06-156.78%3.0M44.4M862.73K
2026-05-296.63%3.0M44.6M806.23K
2026-05-155.79%2.6M44.6M781.82K
2026-04-304.32%2.0M45.8M810.32K
2026-04-154.36%2.0M45.8M852.79K
2026-03-314.53%2.1M45.8M882.57K
2026-03-134.16%1.9M45.8M845.55K
2026-02-275.91%2.7M45.8M846.54K
2026-02-135.54%2.5M45.8M868.35K
2026-01-305.27%2.4M45.7M906.31K
2026-01-156.68%3.1M46.1M844.38K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call55.0064.2067.800.003.7170.000.000.985-0.1080.007
call60.0059.2062.800.003.3500.000.000.983-0.1070.008
call65.0054.2057.800.003.0380.000.000.981-0.1060.009
call70.0049.2052.800.002.7250.000.000.979-0.1050.010
call75.0044.2047.8052.102.4205.000.000.977-0.1030.011
call80.0039.2042.8047.202.1797.000.000.951-0.1930.019
call85.0034.2037.800.001.9280.000.000.945-0.1880.021
call90.0029.3032.600.001.6300.000.000.896-0.3230.034
call95.0024.3027.600.001.4110.000.000.882-0.3070.038
call10019.3022.6021.431.1842.000.000.848-0.3310.045
call10514.5017.7018.300.9891100.000.821-0.3050.050
call1109.7012.8012.710.7899.000.000.779-0.2780.056
call1155.608.502.200.6613260.000.701-0.2600.066
call1202.555.003.700.59482.000.000.555-0.2390.075
call1250.653.900.910.73382.000.000.406-0.2890.074
call1300.003.101.370.8467080.000.314-0.3130.067
call1350.002.551.650.9443.000.000.254-0.3220.061
call1400.002.250.261.0551,0160.000.213-0.3250.055
call1450.002.150.891.18143.000.000.189-0.3390.052
call1500.000.050.091.3121.000.000.175-0.3570.049
call1550.000.751.100.6761.000.000.012-0.0220.006
call1600.000.750.500.74910.000.000.011-0.0220.005
call1650.000.750.250.8221.000.000.010-0.0230.005
put55.000.002.150.002.5490.000.00-0.015-0.1020.007
put60.000.001.750.002.2940.000.00-0.017-0.1010.008
put65.000.002.150.202.0591.000.00-0.019-0.0990.009
put70.000.002.150.251.8402.000.00-0.021-0.0970.010
put75.000.000.300.302.5602.000.00-0.081-0.4040.029
put80.000.002.150.521.7323.000.00-0.049-0.1850.019
put85.000.000.750.591.5232.000.00-0.055-0.1790.021
put90.000.001.750.051.6624.000.00-0.104-0.3130.034
put95.000.001.750.101.4352.000.00-0.118-0.2970.038
put1000.002.150.251.3065210.00-0.152-0.3200.045
put1050.002.150.101.0787280.00-0.179-0.2930.050
put1100.002.252.200.86732.000.00-0.221-0.2660.056
put1150.002.701.400.6961680.00-0.301-0.2480.066
put1200.653.503.900.5243100.00-0.446-0.2250.075
put1253.607.006.700.61353.000.00-0.596-0.2740.074
put1308.1011.209.900.7169.000.00-0.686-0.2980.068
put13512.7015.900.000.8320.000.00-0.746-0.3070.061
put14017.6020.800.000.9840.000.00-0.787-0.3090.055
put14522.5025.900.001.1350.000.00-0.811-0.3230.052
put15027.5030.800.001.2460.000.00-0.987-0.0050.006
put15532.3035.8036.001.3790.000.00-0.988-0.0050.006
put16037.3040.800.001.4990.000.00-0.989-0.0050.005
put16542.3045.800.001.6100.000.00-0.990-0.0050.005

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-26SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-088-KCurrent report2026-10-08SEC
2026-08-188-KCurrent report2026-08-18SEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-06S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-27SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-283Initial statement of beneficial ownership of securities2026-07-24SEC
2026-07-288-KCurrent report2026-07-24SEC
2026-06-09ARSAnnual report to security holders. 2026-03-28SEC
2026-06-09DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-06-09DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-03-28SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-058-KCurrent report2026-06-05SEC
2026-05-28SDSpecialized Disclosure ReportSEC
2026-05-2010-KAnnual report pursuant to Section 13 or 15(d)2026-03-28SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1198.78K100

Institutional holders

Manager% owned
BlackRock, Inc.13.00%
Neuberger Berman Group LLC9.20%
STATE OF WISCONSIN INVESTMENT BOARD8.90%
INCOME RESEARCH & MANAGEMENT5.65%
VANGUARD PORTFOLIO MANAGEMENT LLC5.60%
AQR CAPITAL MANAGEMENT LLC4.99%
ARIEL INVESTMENTS, LLC4.53%
VANGUARD CAPITAL MANAGEMENT LLC4.53%
STATE STREET CORP4.00%
CITADEL ADVISORS LLC3.32%

Funds

Fund% owned
Invesco Equity and Income Fund113.45%
Franklin Convertible Securities Fund68.21%
iShares Convertible Bond ETF30.15%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF23.31%
Miller Market Neutral Income Fund22.00%
Fidelity Convertible Securities Fund16.59%
Invesco V.I. Equity and Income Fund12.37%
EUBEL BRADY & SUTTMAN INCOME AND APPRECIATION FUND11.00%
Touchstone Funds Group Trust-Touchstone Ares Credit Opportunities Fund8.19%
Miller Intermediate Bond Fund7.70%

OakChart. HAE. Cached 15 minutes.

Some panels did not load: insider.